ArticleInternational journal of hepatology2012
Treatment of neuroendocrine tumor liver metastases.
Article in International journal of hepatology, 2012. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers, 1 of them a synthesis that pooled it.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
17 citing papers in PubMed, 1 synthesis or guideline pooled it, 40 citations in OpenAlex.
- Cryotherapy for liver metastases.The Cochrane database of systematic reviews · 2019Pooled it
- Neuroendocrine liver metastasis.Hepatobiliary surgery and nutrition · 2025Article
- A Rare Case of Large-Cell Neuroendocrine Carcinoma Metastasizing to the Brain: A Case Report.Cureus · 2024Article
- Liver Resection for Gastroenteropancreatic Neuroendocrine Tumors with Extrahepatic Disease.Journal of clinical medicine · 2024Article
- Comparison ofCurrent oncology (Toronto, Ont.) · 2024Article
- Review
- IGF2BP1 Promotes Proliferation of Neuroendocrine Neoplasms by Post-Transcriptional Enhancement of EZH2.Cancers · 2022Article
- The new WHO classification of gastrointestinal neuroendocrine tumors and immunohistochemical expression of somatostatin receptor 2 and 5.Experimental and therapeutic medicine · 2021Article
- Direct costs of carcinoid syndrome diarrhea among adults in the United States.World journal of gastroenterology · 2019Article
- Resection of the primary tumor improves survival in patients with gastro-entero-pancreatic neuroendocrine neoplasms with liver metastases: A SEER-based analysis.Cancer medicine · 2019Article
- Evaluation and Management of Neuroendocrine Tumors of the Pancreas.The Surgical clinics of North America · 2019Review
- Evidence-Based Policy in Practice: Management of Carcinoid Syndrome Diarrhea.P & T : a peer-reviewed journal for formulary management · 2019Article
- Nothing But NET: A Review of Neuroendocrine Tumors and Carcinomas.Neoplasia (New York, N.Y.) · 2017Review
- Guidelines for the management of neuroendocrine tumours by the Brazilian gastrointestinal tumour group.Ecancermedicalscience · 2017Article
- Percutaneous image-guided cryoablation: current applications and results in the oncologic field.Medical oncology (Northwood, London, England) · 2016Review
- Liver Ablation: Best Practice.Radiologic clinics of North America · 2015Review
- Role of surgery and transplantation in the treatment of hepatic metastases from neuroendocrine tumor.World journal of gastroenterology · 2014Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
2 authors at 1 institution in 1 country.
Funding
No grant is acknowledged in the PubMed record.
Abstract
In the care of patients with hepatic neuroendocrine metastases, medical oncologists should work in multidisciplinary fashion with surgeons, interventional radiologists, and radiation oncologists to assess the potential utility of liver-directed and systemic therapies. This paper addresses the various roles and evidence basis for cytoreductive surgery, thermal ablation (radiofrequency, microwave, and cryoablation), and embolization (bland embolization (HAE), chemoembolization (HACE), and radioembolization) as liver-directed therapies. Somatostatin analogues, cytotoxic chemotherapy, and the newer agents everolimus and suntinib are discussed as a means for controlling intra- and extrahepatic disease, along with peptide receptor radiotherapy (PRRT). Finally, the experience with orthotopic liver transplant for neuroendocrine tumors is described.
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.